Infection and infectious diseases, Guidance
48 results
Applied filters
Co-amoxiclav for human and animal bites
27 November 2025SPS PGD template for supply of co-amoxiclav for the prophylaxis of human and animal bites in specified patient groups.
Doxycycline and metronidazole for human and animal bites
27 November 2025SPS PGD templates for supply of doxycycline and metronidazole for the prophylaxis of human and animal bites in specified patient groups
Gentamicin: informing intrathecal risk assessment
29 October 2025Gentamicin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Trimethoprim for Urinary Tract Infection (UTI)
2 October 2025SPS PGD template for the supply of trimethoprim tablets for the treatment of Urinary Tract Infection (UTI).
Nitrofurantoin for Urinary Tract Infection (UTI)
2 October 2025SPS PGD template for the supply of nitrofurantoin capsules/tablets for the treatment of Urinary Tract Infection (UTI).
Vancomycin: informing intrathecal risk assessment
1 October 2025Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Colistimethate sodium: informing intrathecal risk assessment
15 August 2025Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Amikacin: informing intrathecal risk assessment
5 August 2025Amikacin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Fluorescein: informing intrathecal risk assessment
8 July 2025Fluorescein products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Choosing between oral vancomycin options
18 June 2025Organisations should choose suitable formulary options for oral vancomycin and mitigate risks. Several factors affect decision making.